Fiji’s HIV Crisis Deepens as Drug Use Fuels New Infections

Fiji is facing one of its toughest health crises in decades, the country has officially declared a national HIV emergency.

This alarming decision comes after a sharp rise in new infections, health officials say drug use is fueling much of the surge.

This Fiji HIV emergency stems from unsafe injecting practices and methamphetamine abuse, sexual transmission has also played a major role in the outbreak.

Advertisement

According to Fiji’s Health Ministry, 2,016 new cases were recorded in 2025 alone, that number reflects a troubling 27 percent jump from the previous year.

Drug trafficking and needle sharing have become key drivers behind the crisis. Meth use, in particular, has worsened the spread significantly.

UNAIDS reports that over 42 percent of cases are linked to drug injection, more than half of all cases stem from sexual transmission instead.

This Fiji HIV emergency has tragically reached the country’s youngest citizens too, in 2025, 59 babies were born with HIV.

Sadly, 18 of those infants died before turning one year old, these numbers highlight just how serious the outbreak has become.

Testing and treatment gaps remain a major concern for health officials, only 39 percent of people with HIV in Fiji know their status.

Even fewer are receiving proper treatment, with just 22 percent accessing care, these figures fall well below global health targets.

In response, the government plans to expand confidential testing nationwide, officials also aim to boost antiretroviral treatment and needle-exchange programs.

International partners have already stepped in to help, australia, New Zealand, India, and the UN have pledged their support.

UNAIDS warned that Fiji’s situation reflects a wider global concern, officials stressed that AIDS remains a real threat, especially where drugs and stigma collide.

Add a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement